Atlas Trials

A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy

Clinical trial NCT03331640 · TERMINATED

Trial details

NCT number
NCT03331640
Sponsor
AIO-Studien-gGmbH
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Ductal Adenocarcinoma
Start date
2018-01-02
Primary completion
2021-09-13
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.